1,027 material Form 8-K filings that 835 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Moelis & Company's Compensation Committee approved a $25 million retention award of profits interest units to Chairman and CEO Ken Moelis, to be granted February 13, 2025. The award vests fully on February 13, 2029, subject to continued employment, and the units cannot be sold until twelve months after vesting, which ties his incentives to the company's longer-term results.
Retention award valued at $25 million, granted to Chairman and CEO Ken Moelis
Four-year cliff vesting on February 13, 2029, subject to continued employment
No sales permitted until the twelve-month anniversary of the vesting date
Unit count to be set using the average Class A share price from February 6 to February 12, 2025
On February 10, 2025, LegalZoom acquired 100% of Formation Nation for up to $64.75 million in cash and 2,205,445 restricted shares, with about $15.4 million of the cash held back for one year. The company also reported preliminary, unaudited 2024 results that it said were at the high end of its outlook range, but those figures may change before final results. Shareholders face dilution from the new shares, and the company expects the deal to add to Adjusted EBITDA and be accretive to Adjusted EPS in the first year.
Cash consideration of up to $64.75 million plus 2,205,445 restricted shares; $49.3 million cash paid at closing and about $15.4 million held back for one year
Preliminary Q4 2024 revenue of about $161.7 million and net income of about $12.9 million; full-year 2024 revenue of about $681.9 million and net income of about $30.0 million
Shares carry a two-year lock-up, with 50% released at each of the first and second anniversaries of closing
Full Q4 and full-year 2024 results and 2025 outlook are scheduled for a conference call on February 26, 2025
Harmonic reported unaudited fourth-quarter 2024 revenue of $222.2 million, up from $167.1 million a year earlier, and GAAP net income of $38.1 million, down from $83.8 million, which included a prior-year tax benefit. The company guided to 2025 GAAP net revenue of $585 million to $645 million and authorized a new $200 million share repurchase program through February 2028.
Q4 2024 GAAP diluted EPS was $0.32, versus $0.72 a year earlier; non-GAAP diluted EPS was $0.45, versus $0.13
Q4 2024 adjusted EBITDA was $71.8 million, versus $21.7 million a year earlier
2025 GAAP net revenue guidance is $585 million to $645 million, with GAAP net income of $22 million to $53 million
Board authorized a new $200 million buyback through February 2028, replacing the existing program
Universal Corp said preliminary results for the quarter ended December 31, 2024 show sales and other operating revenue of $937.2 million and diluted earnings per share of $2.27, but it has delayed its third-quarter earnings release and Form 10-Q. The delay follows an internal investigation into embezzlement at its Mozambique subsidiary, which has identified about $16.7 million in unauthorized payments over fiscal years 2016 through 2025, and the company expects to report one or more material weaknesses in internal control over financial reporting.
Preliminary quarter ended December 31, 2024: sales and other operating revenue $937.2 million, operating income $100.7 million, net income $57.1 million, diluted EPS $2.27.
Internal investigation has identified about $16.7 million in unauthorized payments in fiscal 2016 through 2025, including about $7 million in fiscal 2022 through 2025.
On February 10, 2025, lenders agreed to extend the deadline for delivering the quarterly financials to June 16, 2025; the company paid a consent fee of 0.05% of each consenting lender's commitment and term loans.
The company does not believe material adjustments to previously issued financial statements will be necessary, but it expects to report one or more material weaknesses in internal control over financial reporting.
Medpace reported fourth-quarter 2024 revenue of $536.6 million, up 7.7%, and GAAP diluted earnings of $3.67 per share, up from $2.46 a year earlier. The board also approved a $600 million increase to the stock repurchase program, and the company forecast 2025 revenue of $2.110 billion to $2.210 billion, growth of 0.0% to 4.8%, for shareholders to weigh against slower new business awards.
Q4 2024 revenue was $536.6 million, up 7.7% from $498.4 million; GAAP net income was $117.0 million.
Q4 2024 net new business awards fell 13.8% to $529.7 million, for a net book-to-bill ratio of 0.99x.
2025 guidance: revenue of $2.110 billion to $2.210 billion and GAAP diluted EPS of $11.93 to $12.69.
On February 6, 2025, the board approved a $600 million increase to the stock repurchase program.
Axcelis reported fourth-quarter 2024 revenue of $252.4 million and diluted EPS of $1.54, and full-year 2024 revenue of $1.02 billion, down from $1.13 billion in 2023. It guided first-quarter 2025 revenue to approximately $185 million and diluted EPS to approximately $0.38, well below fourth-quarter levels. Full-year diluted EPS fell to $6.15 from $7.43, and the company cited a near-term cyclical digestion period among its customers.
Q4 2024 revenue was $252.4 million, down from $310.3 million in Q4 2023 and $256.6 million in Q3 2024
Q4 2024 diluted EPS was $1.54, up from $1.49 in Q3 2024 but down from $2.15 in Q4 2023
Full-year 2024 revenue was $1.02 billion vs. $1.13 billion in 2023; diluted EPS was $6.15 vs. $7.43
Q1 2025 outlook: revenue of approximately $185 million and diluted EPS of approximately $0.38
Lattice reported fourth-quarter 2024 revenue of $117.4 million, down 31.2% from a year earlier, and full-year revenue of $509.4 million, down 30.9%. GAAP diluted earnings were $0.12 per share in the quarter, against $0.71 a year earlier, and it guided first-quarter 2025 revenue to $115 million to $125 million. The company also appointed Lorenzo A. Flores as CFO effective February 10, 2025.
Q4 2024 revenue $117.4 million, down 7.6% from Q3 2024 and down 31.2% from Q4 2023; GAAP diluted EPS $0.12 versus $0.71 a year earlier
Full-year 2024 revenue $509.4 million versus $737.2 million in 2023; GAAP diluted EPS $0.44 versus $1.85
Q1 2025 outlook: revenue $115 million to $125 million; non-GAAP diluted EPS $0.20 to $0.24
Lorenzo A. Flores named SVP and CFO effective February 10, 2025, with a $600,000 base salary; Tonya Stevens moves to Chief Accounting Officer
Manhattan Associates said Eddie Capel will retire as President and CEO effective February 12, 2025, and be succeeded by Eric Clark, most recently CEO of NTT Data North America. Capel becomes Executive Vice-Chairman, and Clark joins the Board, which expands from eight to nine members. The filing discloses Clark's pay package, including a $800,000 base salary and an $8 million equity grant, and does not include any financial results.
Eric Clark succeeds Eddie Capel as President and CEO effective February 12, 2025
Clark's package includes an $800,000 base salary, an $800,000 target bonus and a $3 million cash signing bonus
Initial equity grant of restricted stock units valued at $8 million at grant, vesting through February 14, 2028
Capel joined Manhattan in June 2000 and has been CEO since January 2013
Incyte reported fourth-quarter 2024 total revenues of $1.2 billion, up 16% year over year, and full-year revenues of $4.2 billion, up 15%. Full-year GAAP net income fell to $32.6 million from $597.6 million, mainly because of a $679.4 million charge for in-process R&D assets acquired with Escient and a $100.0 million milestone payment to MacroGenics. The company also gave 2025 guidance for Jakafi and Opzelura net product revenues.
Q4 2024 GAAP net income was $201.2 million, or $1.02 per diluted share, versus $201.1 million, or $0.89, a year earlier
Full-year 2024 GAAP diluted EPS was $0.15, compared with $2.65 in 2023
2025 guidance: Jakafi net product revenues of $2,925 million to $2,975 million; Opzelura $630 million to $670 million
Cash, cash equivalents and marketable securities were $2.2 billion at December 31, 2024, down from $3.7 billion, mainly due to a $2.0 billion share repurchase in June 2024
Rockwell Automation reported fiscal first-quarter 2025 sales of $1,881 million, down 8.4% from a year earlier, with diluted EPS of $1.61, down 13%. The company lowered its fiscal 2025 reported sales growth range to (5.5)% to 0.5%, citing about (1.5)% of currency impact, while reaffirming its EPS guidance. Shareholders face lower quarterly sales and profit, though the company's EPS guidance was unchanged.
Sales were $1,881 million, down 8.4% from $2,052 million; organic sales fell 7.6%.
Diluted EPS was $1.61 versus $1.86 a year ago; adjusted EPS was $1.83 versus $2.04.
Fiscal 2025 reported sales growth guidance cut to (5.5)% to 0.5% from (4)% to 2%; diluted EPS guidance of $7.65 to $8.85 reaffirmed.
Orders rose about 10% year over year, and the company repurchased shares for $99 million in the quarter.
3M announced board changes: CEO William Brown will also become Chairman effective March 1, 2025, replacing Executive Chairman Michael Roman, who retires from the board that day and from the company on May 1, 2025. The board also added David Bozeman as an independent director effective February 6, 2025, while Amy Hood will not stand for re-election in 2025. The filing reports leadership and governance changes only, with no financial results.
William M. Brown, CEO, appointed Chairman of the Board effective March 1, 2025, in addition to his CEO role
Michael F. Roman retires as Executive Chairman and Director effective March 1, 2025, and serves as Executive Advisor until retiring from 3M on May 1, 2025
David P. Bozeman, President and CEO of C.H. Robinson Worldwide, elected to the Board effective February 6, 2025 and appointed to the Science, Technology and Sustainability Committee
Amy E. Hood does not intend to stand for re-election at the 2025 annual shareholder meeting
Edgewell reported first-quarter fiscal 2025 net sales of $478.4 million, down 2.1%, and a GAAP loss of $0.04 per diluted share, versus earnings of $0.09 a year earlier. The company lowered its full-year GAAP EPS outlook to $2.54 to $2.74 from $2.59 to $2.79, citing foreign currency changes, and said adjusted EPS will be toward the lower end of its $3.15 to $3.35 range. Shareholders also voted at the February 6, 2025 annual meeting, re-electing all ten director nominees and approving the auditor and executive pay proposals.
Net sales were $478.4 million versus $488.9 million a year earlier; organic net sales decreased 1.3%.
GAAP diluted EPS was $(0.04) versus $0.09; adjusted EPS was $0.07 versus $0.24, including a $0.17 unfavorable currency impact.
Full-year fiscal 2025 GAAP EPS outlook was lowered to $2.54 to $2.74 from $2.59 to $2.79; adjusted EPS is now expected toward the lower end of $3.15 to $3.35.
At the February 6, 2025 annual meeting, all ten director nominees were elected and PricewaterhouseCoopers LLP was ratified as auditor.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.